Higher smoking prevalence among people with HIV in almost all world regions
São Paulo patient experiences apparent viral rebound a year and a half after stopping HIV treatment
‘Resilient’ HIV programmes in African countries have maintained viral suppression during the COVID-19 pandemic
What are the roles of TAF and integrase inhibitors in weight gain?
PrEP does not lower hormone levels in young transgender people, but lower PrEP levels seen in some transgender women
Four-days-on, three-days-off treatment regimen still looks effective after two years
Injectable HIV medications must be practical and affordable, conference hears
To be cost-effective, injectable PrEP can only cost about $3000 more than US generic oral PrEP
Gender-affirming surgery associated with sustained viral suppression
